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InvasionHSP90, a major molecular chaperone, plays an essential role in the maintenance of several signaling
molecules. Inhibition of HSP90 by inhibitors such as 17-allylamino-demethoxy-geldanamycin (17AAG) is
known to induce apoptosis in various cancer cells by decreasing the activation or expression of pro-survival
molecules such as protein kinase B (Akt). While we did not observe either decrease in expression or activation
of pro-survival signaling molecules in human breast cancer cells upon inhibiting HSP90 with 17AAG, we did
observe a decrease in cell motility of transformed cells, and cell motility and invasion of cancer cells. We found
a significant decrease in the number of filopodia and lamellipodia, and in the F-actin bundles upon HSP90
inhibition. Our results show no change in the active forms or total levels of FAK and Pax, or in the activation of
Rac-1 and Cdc-42; however increased levels of HSP90, HSP90α and HSP70 were observed upon HSP90
inhibition. Co-immuno-precipitation of HSP90 reveals interaction of HSP90 with G-actin, which increases
upon HSP90 inhibition. FRET results show a significant decrease in interaction between actin monomers,
leading to decreased actin polymerization upon HSP90 inhibition. We observed a decrease in the invasion of
human breast cancer cells in the matrigel assay upon HSP90 inhibition. Over-expression of αB-crystallin,
known to be involved in actin dynamics, did not abrogate the effect of HSP90 inhibition. Our work provides
the molecular mechanism bywhich HSP90 inhibition delays cell migration and should be useful in developing
cancer treatment strategies with known anti-cancer drugs such as cisplatin in combination with HSP90
inhibitors.olecular Biology, Uppal Road,
+91 40 27160591.
l rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
The heat shock protein 90 (HSP90) is an ATPase-directedmolecular
chaperone, which comprises 1–2% of the total cellular protein content
[1]. Its contribution to various cellular processes including signal
transduction, protein degradation, protein folding, maturation of
client proteins [2] and protein trafficking among sub-cellular compart-
ments has been extensively studied [1,3,4]. HSP90 is up-regulated in
cancer and its ATPase activity is increased ~50-fold [2], marking it as a
promising target for anti-cancer therapy. The cell permeable HSP90
antagonist 17-allylamino-demethoxy-geldanamycin (17AAG) [5–7],
presently in phase III clinical trials, competeswith ATP and inhibits the
ATPase activity of HSP90 [7]. Studies from our laboratory and others
have shown that inhibition of HSP90 by geldanamycin and 17AAG
leads to induction of apoptosis in various tumor cell types including
solid tumors [8,9]. Metastasis, cancer cell migration and invasion into
adjacent tissues and intravasation into blood/lymphatic vessels [10], is
the cause of most cancer deaths [11]. Thus, a combined strategy ofeliminating the cancer cells by inducing apoptosis and preventing
metastasis should be more effective in treatment of cancer.
Cell migration during different processes such as differentiation and
cancer is regulated by different mechanisms [12] which are common to
both neoplastic and cancer cells. Cell migration requires extensive
reorganization of actin network involving equilibrium processes (actin
dynamics) between its globular (G) and filamentous (F) forms [13].
Reorganization of actin in response to environmental stimuli, such as
extra-cellular matrix (ECM) molecules (e.g. fibronectin) and growth
factors, leads to formation of cell protrusions, lamellipodia and filopodia
which act as locomotory and sensory apparatus of the cell help in its
guidedmotion [14]. Cancer cells alsouse these protrusions formigration
through the ECM to establish new tumor sites [13]. Rho small family
GTPases such as Rho, Rac and Cdc42 [15] play a role in regulating the
cytoskeleton by binding GTP and recruiting a range of target proteins
thereby bringing about actin reorganization. Rho A promotes formation
of actin stressfibers and leads to generation of contractile forces [16,17].
Rac1 signaling promotes formation of large membrane protrusions
(branched network of actin) called lamellipodia [18], whereas Cdc42
signaling leads to the formation of actin-rich spikes calledfilopodia [15].
These proteins are known to activate the actin-related protein (Arp) 2/3
complex, resulting in rapid actin polymerization at sites where
rearrangements of actin cytoskeleton is needed [19,20]. Inhibition
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metastasis.
HSP90 is known to bind actin in vitro [20–22]; however its function
with respect to actin dynamics is unclear. Proteomic analysis of tumor
cell pseudopodial protrusions showed higher levels of HSP90 compared
to the cell body [23]. HSP90 is important in maintaining cell
morphology, migration and activation of matrix metalloproteinase 2
(MMP2), a key player in matrix degradation and cancer cell invasion
[24–26]. However, the higher level of HSP90 observed in tumor cell
protrusions and its relation to actin dynamics and cell migration are not
well understood.
We have investigated the effect of HSP90 inhibition by 17AAG on
the migration, actin dynamics and signaling pathways in transformed
rat fibroblast cells, F111, andMDA-MB-231 human breast cancer cells.
Our study reveals the mechanistic details involving multiple path-
ways such as binding to G-actin and inhibiting its polymerization,
decreasing RhoA levels and decreasing the translocation of HSP90α to
the cell surface upon HSP90 inhibition.
2. Materials and methods
2.1. Plasmids, drugs and antibodies
The constructs ECFP-Actin and EYFP-Actin were a gift from
Dr. Yasunori Hayashi (RIKEN-MIT Neuroscience Research Centre,
Massachusetts, USA). The αB-crystallin-FLAG fusion construct was
described previously [27].
17-AAG (NIH, Bethesda, Maryland, USA) was dissolved in DMSO
(Sigma, USA) and was used at a final concentration of 2 μM. DMSO-
treated cells were considered as control cells.
Primary antibodies FAK (#3258), p-Tyr397-FAK (#3281), paxillin
(#2542), p-Tyr118-paxillin (#2541), P-38 (#9212) and p-Thr202/
Tyr204-ERK1/2 (#9101) were obtained from Cell Signaling (Beverly,
MA, USA). Antibodies for HSP90 (#SPA-846), HSP90α (#SPS-771),
HSP90β (#SPA-842), HSP70 (#SPA-810), HSP25 (#SPA-801), HSP27
(#SPA-800), αB-crystallin (#SPA-223) and p-Ser-59-αB-crystallin
(#SPA-227) were obtained from Stressgen (Victoria, BC, Canada).
Antibodies for RhoA (#sc-179), mDia2 (#sc-55540), Cdc42 (#sc-8401),
Akt1/2 (#sc-8312) and p-Thr308-Akt1/2 (#sc-16646-R) were obtained
from Santa Cruz Biotechnology (Santa Cruz, CA, USA). RhoA (#05-
778), Rac1 (#05-389) and Arp2/3 (#07-227) were from Upstate (Lake
Placid, NY, USA). GAPDH (#MAB374) and Actin (#MAB1501) were
obtained from Chemicon International (Temecula, CA, USA). p-Thr180/
Tyr182-P-38 (#612280) was from BD Transduction Laboratories (San
Diego, CA, USA). Horse radish peroxidase (HRPO)-conjugated anti
mouse/rabbit was obtained from Roche (Indianapolis, IN, USA) and
HRPO conjugated anti-goat was obtained from Stressgen (Victoria, BC,
Canada). Secondary antibodies for immunofluorescence were obtained
from Molecular Probes (Eugene, OR, USA), Zymed Laboratories (San
Francisco, CA, USA) and Sigma (St. Louis, USA).
2.2. Cell culture, transfection, and stable clone selection
Transformed rat fibroblast cell line, F111, and human breast cancer
cell line, MDA-MB-231 were obtained from American Type Culture
Collection (ATCC, USA) and maintained in DMEM (Invitrogen, USA)
supplementedwith 10% FBS (Invitrogen, USA) in a humified incubator
at 37 °C with 5% CO2. Cells, when 80% confluent, were transfectedwith
200 ng of vector using Lipofectamine-2000™-plus reagent (Invitrogen,
USA) diluted in incomplete DMEM. Incomplete DMEM was replaced
with DMEM supplemented with 10% FBS after 24 h of transfection. The
cells treated with or without HSP90 inhibitor were fixed for immunos-
taining with formaldehyde.
For generation of stable clones, MDA-MB-231 cells after transfec-
tion serially diluted against DMEM to 1:1000, 1:500, 1:250 and 1:100
and allowed to grow in the selection medium containing Geneticin(G418) (800 μg/ml). Single colonies were picked and plated on 96-
well plate. The clones were further passaged (using 24-well plate and
then into T-25 flasks). The clones were screened for the protein
expression by immuno-blot and immunofluorescence. The positive
clones were selected and used for further experiments.
2.3. Immuno-blot analysis and fluorescence microscopy
Whole cellular protein was extracted by incubating cells in 50 mM
Tris–Cl buffer, pH-8.0, containing, 1% Triton X-100, 1% sodium
deoxycholate, 0.1% sodium dodecyl sulphate, 150 mM sodium chloride,
1×protease inhibitor (Sigma), 1×phosphatase inhibitor (Sigma) and
1 mM sodium orthovanadate for 30 min on rototorque at 4 °C. The mix
was centrifuged at 4500 g for 25 min at 4 °C. The protein in the resulting
supernatant was quantified by the Bradford method (Biorad, Hercules,
CA, USA) according to the instructions of the manufacturer, diluted 1:4
inprotein SDS loadingbuffer, andheated to95 °C for 5–10 min.A total of
50 μg of protein was loaded onto 8%, 10% and 12% Tris–HCl SDS-
polyacrylamide electrophoresis gels as required, transferred to Hybond
C-extra nitrocellulose membrane (Amersham Biosciences, NJ, USA)
using wet transfer apparatus (Biorad, Hercules, CA, USA ). The
membrane was then incubated in blocking solution (5% BSA in Tris
Buffered Saline (TBS) containing 0.1% Tween-20) for 2 h with gentle
rocking at room temperature. Primary antibody was diluted (in 3% BSA
in TBS) according to theprescribeddilutionsby themanufacturer orwas
standardized by checking various dilutions. The membrane was
incubated for 3–4 h at room temperature or overnight at 4 °C in primary
antibody. After washing for 10 min in TBS containing 0.1% Tween-20
(TBST) thrice, the membranes were incubated in secondary antibody
conjugated with HRPO. After washing for 10 min in TBST thrice, the
substrate (BM Chemiluminescence kit, Roche) was added on the
membrane and was developed using Kodak X-ray films.
For immunofluorescence analysis, cells were fixed in 3.5%–4%
formaldehyde with 0.5% Triton X-100+0.05% Tween-20/PBS, washed
three times with PBS and incubated with rhodamine-phalloidin
(1:100; Molecular Probes, Eugene, OR) for 1 h before three washes
with PBS and mounting. For cells that were stained with antibodies,
the procedure was essentially as mentioned earlier, except that a
primary antibody was used in place of phalloidin before incubation
with fluorescently-conjugated secondary antibodies, and then was
stained with rhodamine-phalloidin. The cells were analyzed and
photographed using a Carl Zeiss 510-Meta LSM or Carl Zeiss 510-Meta
LSM with multi-photon laser (Chameleon) microscope (Carl Zeiss,
GmbH, Germany) or Leica-TCS-SP5 confocal microscope (Leica Micro-
systems, Germany). The images were further processed using Adobe
Photoshop version-7.0.
2.4. Immuno-precipitation and GTPase activation assay
F111 and MDA-MB-231 cells were incubated with modified RIPA
lysis buffer (50 mM Tris–Cl pH-7.4, 150 mM NaCl, 1 mM EDTA, and
1 mM PMSF, 1×protease inhibitor, 1 mM sodium orthovanadate and
0.01% NP-40) for 5 min and centrifuged at 10,000 g for 25 min at 4 °C.
The supernatant was considered as the soluble fraction and the pellet
as the in-soluble fraction. Preclearing of the soluble fraction was done
by incubation with Protein A sepharose beads (#17-0469-01,
Amersham Biosciences, Uppsala, Sweden) for 1 h in a rototorque at
4 °C. The lysate was further incubated with anti-HSP90 antibody for
16–20 h in a rototorque at 4 °C. Total cell lysate was used for immuno-
precipitation of αB-crystallin. Secondary antibodies coupled with
magnetic beads (Bangs Laboratories Inc., Fishers, IN, USA) were added
to the mix and was incubated for 4 h in a rototorque at 4 °C. The
magnetic beads were then precipitated using magnetic adapters and
heated at 100 °C after addition of sample solubilizing buffer. The
samples were resolved using 12% polyacrylamide gel electrophoresis
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was performed for the proteins of interest.
For GTPase activation assay the protocol provided by the manufac-
turer of the Rac-Cdc42 activation assay kit (#17-441, Millipore
Corporation, Temecula, CA, USA) was followed.
2.5. Wound healing assay and analysis
Wounds were made by scraping with a pipette tip in the confluent
culture of cells plated in a 4 mm dish. Wound healing was monitored
using 20× objective lens of a live cell microscope (Carl Zeiss, GmbH,
Germany), having 5% CO2 supply at 37 °C, in the presence and absence
of 17AAG for 20 h in F111 cells, 28 h in MDA-MB-231 cells and 36 h in
CryαB-MDA-MB-231 cells. Image was acquired every 3 min and
processed as a movie. Analysis of 20 cells was done by clicking on the
nucleus of the cell for each frame using Metamorph software and the
average speed and standard error were calculated before plotting the
bar graph.
2.6. FRET analysis
MDA-MB-231 cells were co-transfected with constructs ECFP-
actin and EYFP-actin in a 4-well chambered cover glass. The cells were
incubated with or without 17AAG for 24 h, after 3–4 days of
transfection. The confocal microscope (Carl Zeiss 510-Meta) was set
using cells transfected with either ECFP-actin or EYFP-actin. FRET
(Acceptor Photobleaching)was performed using themacro of the LSM
software.
2.7. Scanning electron microscopy of the cells plated on matrigel
MDA-MB-231 andCryαB-MDA-MB-231 cellswereplatedon layer of
matrigel (#354234; Bedford; MA; USA) (diluted 1:1 in PBS) and
incubated for 2 days in the presence of complete medium for adhesion.
The cells were then incubated with or without HSP90 inhibitor for 24 h
and thenwerefixedwith2.5%glutaraldehyde (diluted in1×PBS) for 2 h
at room temperature. After washing three times with PBS the sample
was dehydrated by incubating cells for 10 min in 30% acetone followed
by 50%, 70%, and 90% acetone (diluted in PBS). The sample was washed
three times for 10 min each in 100% acetone and finally with amyl
acetate. Critical point drying of the sample was done and scanning
electron microscopy (Hitachi, Japan) was performed.
2.8. Analysis of cell migration/invasion assay
F111, MDA-MB-231 and CryαB-MDA-MB-231 cells were plated on
the upper chamber of the collagen IV (final concentration-50 μg/μl;
#C5533, Sigma, St. Louis, USA) coated 12-well transwell separated
with a membrane having 5 μm pore size (#3421, Costar, Corning, NY,
USA). The cells were allowed to adhere for 24 h. The cells were then
allowed to migrate to the other side of the membrane, with the upper
chamber having serum-free DMEM with or without 17AAG and the
lower chamber having serum-containing DMEM. After 24 h, the cells
were taken out from the other side of the membrane using a cotton
swab and were counted after staining with 0.1% Trypan Blue.
For invasion assay, the upper chamber of the transwell was coated
with 100 μl of matrigel (diluted 1:1 in PBS) and left to solidify for
30 min at 37 °C. 100 μl of MDA-MB-231-GFP cells (8×105 cells/ml)
was plated on the other side of the membrane of the matrigel plugged
transwell (that is facing towards the lower chamber). The cells were
left to adhere for 4 h and then the transwell was placed in a 24-well
plate. The lower chamber was filled with serum-free DMEM with or
without 17AAG and the upper chamber was filled with serum-
containing DMEMwith or without Epidermal Growth Factor (400 ng).
The cells were allowed to invade for 24 h and live cell confocal
microscopy was performed using the 20× lens of multi-photon laserof Carl Zeiss 510-Meta multi-photon laser scanning confocal micro-
scope. Analysis and 3D reconstruction of the images were done using
Imaris software.
3. Results
3.1. Inhibition of HSP90 function decreases cell motility and cellular
protrusions
We performed the scratch wound healing assay in the presence or
the absence of HSP90 inhibitor, 17AAG, in F111 and MDA-MB-231 cells.
Migration was monitored by time lapsed photography with a live cell
microscopeanddataprocessed as amovie. F111 cells, incubatedwith the
vehicle (DMSO), migrated in a synchronous manner with an average
speed of 17×10−4 μm/min (graph, Fig. 1A) and were able to heal the
wound in 16 h (Movie M1). However, in the presence of 17AAG, F111
cells migrated almost three-fold slower (6×10− 4 μm/min;
graph Fig. 1A) and stopped migrating after 6 h (Movie M2). In contrast,
MDA-MB-231 cells showed non-synchronous motion, with some of the
cells squeezing out and migrating faster compared to the others; these
cells did not heal the wound even after 28 h (Movie M3). The average
speed of MDA-MB-231 cells was found to be 5×10−4 μm/min
(graph Fig. 1B) while that of MDA-MB-231 cells incubated with 17AAG
was found to be 3.2×10−4 μm/min. Detailed analysis of the movies
reveals development offinefilopodia-like structures at the leadingedges
of the migrating F111 cells (Movie M1), whereas MDA-MB-231 cells
show extensive formation of lamellipodia with dark spots at their
leading edges in the absence of 17AAG (Movie M3). Interestingly, we
observed occasional retraction of the fine protrusions in addition to the
decrease in their number in F111 cells (Movie M2), whereas decreased
lamellipodia formation and significant reduction in the dark spots at the
leading edges in MDA-MB-231 cells was observed upon HSP90
inhibition (Movie M4).
The initial step in cell migration is the reorganization of actin
cytoskeleton. We examined whether HSP90 inhibition leads to altera-
tions in actin reorganization by staining the cells in the wound healing
assay with phalloidin, which binds to filamentous actin (F-actin)
bundles. Staining with phalloidin reveals fine filopodial structures in
F111 cells (Fig. 1C). The DIC image as well as the inset of the DIC image
shows a significant number of filopodia all over the cells (Fig. 1C).
Inhibition of HSP90 in F111 cells leads to a decrease in the number of
filopodia (Fig. 1C). Incubation ofMDA-MB-231 cells with 17AAG leads to
decrease in the tough cortical actinbundles as seen in theupper z-section
of the confocalmicrograph (Fig. 1D, panel 2) and a significant decrease in
the membrane ruffles (enlarged view, Fig. 1D). Further, both the cell
types showed a significant decrease in F-actin. Interestingly, actin
bundles at the cell periphery showed curved trajectories upon HSP90
inhibition compared to the actin filaments arranged at higher angles to
the cell front in control F111 cells (Fig. 1C) and control MDA-MB-231
cells (Fig. 1D).
Taken together, these data suggested that HSP90 inhibition leads
to decreased cell motility, decrease in the number of filopodia and
lamellipodia, and tough cortical actin bundles.
3.2. Status of signalingmolecules involved in adhesion, actin polymerization
and actin dynamics, and levels of heat shock proteins and pro-survival
signaling molecules upon HSP90 inhibition
Molecular interactions between the cell and the substratum lead to
adhesion; molecular assembly and disassembly at the adhesion points,
thereby, regulate cell motility. No significant change in the levels of FAK
and Pax, themainmolecules of the focal adhesion complex, but a minor
increase inp-Tyr397-FAKandadecrease in p-Tyr118-Paxwere observed
in F111 cells uponHSP90 inhibition (Fig. 2A). Levels of Arp2/3, known to
be involved in rapid actin polymerization [28], also did not change upon
HSP90 inhibition (Fig. 2A). These results indicate no significant change in
Fig. 2. Change in levels of HSPs and signaling molecules involved in F111 and MDA-MB-231 cells upon HSP90 inhibition. (A) Immuno-blot analysis of FAK, p-Tyr397-FAK, Pax,
p-Tyr468-Pax and Arp2/3 in 17AAG-treated and untreated cells. (B) GTPase pull-down for Rac1 (upper panel). Confocal images of RhoA andmDia2 in 17AAG-treated and untreated
MDA-MB-231 cells. Scale bar, 10 μm. (C) Immuno-blot analysis of Akt1/2, p-Ser308-Akt1/2 and p-Thr202/Tyr204-ERK1/2 for 17AAG-treated and untreated cells. (D) Immuno-blot
analysis of HSP90, HSP70, HSP25 and HSP27 for 17AAG-treated and untreated cells. Actin is used as a loading control.
Fig. 1. Decreased motility and cellular protrusions in F111 and MDA-MB-231 cells upon treating with 17AAG for 24 h. (A) Motility of F111 cells in the presence or absence of 17AAG
(2 μM). (B) Motility of MDA-MB-231 cells in the presence or absence of 17AAG (2 μM). (C) Confocal images of F-actin staining by phalloidin coupled with rhodamine of 17AAG-
treated and untreated F111 cells. (D) Confocal images of F-actin staining by phalloidin coupled with rhodamine of 17AAG-treated and untreated MDA-MB-231 cells. The graphs in
panels A and C represent the average motility of 20 cells±S.E. of two independent experiments. Scale bar in the DIC panel (panels C and D), 10 μm.
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tion upon HSP90 inhibition.
We have investigated the status of Rho family of small GTPases, the
key regulators of both cell adhesion and actin cytoskeleton, in F111 and
MDA-MB-231 cells. No significant change in the levels of Rac1 and
Cdc42 (Fig. S1), known to be involved in the formation of lamellipodia
and filopodia respectively, was observed upon HSP90 inhibition.
Immuno-blot analyses of the GTPase pull-down assay for Rac1 and
Cdc42 show no change in the activation of Rac1 (Fig. 2B, upper panel)
and Cdc42 (data not shown) upon HSP90 inhibition. We investigated
RhoA andmDia2, theproteins known tobe involved in the generation of
contractile force [16] and in the formation of lamellipodia [29]
respectively by immuno-blot and immunofluorescence analysis and
found a significant decrease in the level of RhoA and depletion ofmDia2
from the cell periphery upon HSP90 inhibition (Figs. 6A and 2B).
Molecules such as Rho GTPases involved in cell migration require
phosphorylation by pro-survival signaling molecules [30] such as
protein kinase B (Akt) and Extra-cellular Regulated Kinase (ERK). A
significant decrease in the levels of Akt1/2 and ERK1/2 was observed
in F111 cells upon HSP90 inhibition (Fig. 2C); however, no change in
the levels of either inactive or active form of Akt1/2 or active form of
ERK1/2 was observed in MDA-MB-231 cells upon incubation with
17AAG (Fig. 2C). Degradation, or decrease in the levels of activation, of
these pro-survival signaling molecules due to HSP90 inhibition propels
cells to undergo apoptosis [8]. We did not observe apoptosis in either
MDA-MB-231 cells or F111 cells until 24 h of HSP90 inhibition.
Up-regulation of HSPs such as HSP70 is known to prevent apoptosis
[31]. Immuno-blot analysis shows drastic increase in the levels of HSP90
and inducible form of HSP70, but not in the levels of HSP25/27, upon
HSP90 inhibition (Fig. 2D).
3.3. Immuno-precipitation and FRET analysis show interaction of HSP90
with soluble actin
We performed immuno-precipitation of HSP90 from the soluble
and the in-soluble fractions of F111 and MDA-MB-231cell lysates
(see Materials and methods) and probed for the proteins involved in
cell migration. Immuno-blot analysis of the immuno-precipitated
samples shows increase in HSP90 in the soluble fraction upon HSP90
inhibition (Fig. 3A). Interestingly, we observed an increase in the pull-
down of actin, possibly G-actin, with HSP90 upon HSP90 inhibition
(Fig. 3A) indicating specific interaction of HSP90 with actin in theFig. 3. Increased association of HSP90 with soluble actin and decrease in G-actin interact
precipitate probed by actin and αB-crystallin antibodies in the soluble fraction. (B) Immuno
and HSP90 antibodies. (C) FRET analysis of MDA-MB-231 cells co-transfected with actin-ECF
without HSP90 inhibition. Error bars indicate ±SEM of 12 cells from four independent expsoluble fraction. αB-Crystallin also precipitated with HSP90 from the
soluble fraction which increased upon HSP90 inhibition in F111 cells
(Fig. 3A). We did not observe pull-down of αB-crystallin with HSP90 in
MDA-MB-231 cells as these cells express low levels ofαB-crystallin (Fig.
S2). To confirm the interaction of HSP90 and αB-crystallin, we over-
expressed αB-crystallin in MDA-MB-231 cells (CryαB-MDA-MB-231),
performed immuno-precipitation with αB-crystallin and probed for
HSP90. We observed pull-down of HSP90 with αB-crystallin in F111
cells and CryαB-MDA-MB-231 cells (Fig. 3B). Further, we also observed
pull-down of αB-crystallin with the immuno-precipitate of HSP90 in
MDA-MB-231 cells over-expressing αB-crystallin (Fig. 3A). We also
probed for actin in the samples immuno-precipitated for αB-crystallin.
These observations clearly suggest increased interaction of HSP90 with
soluble formof actin (G-actin) andαB-crystallin uponHSP90 inhibition,
whichmight be responsible for the decreased actin tread-milling at the
cell periphery.
To further probe the effect of HSP90 inhibition on actin dynamics,
we transfected MDA-MB-231 cells with actin-ECFP and actin-EYFP
vector and performed Förster Resonance Energy Transfer (FRET) in
the presence and absence of 17AAG. We bleached the acceptor, actin-
EYFP, and looked for the increase in the fluorescence of the donor,
actin-ECFP. We observed 18% FRET efficiency in control MDA-MB-231
cells (DMSO-treated), whereas MDA-MB-231 cells incubated with
17AAG for 24 h showed ~9% FRET efficiency, a 50% decrease compared
to the control cells (Fig. 3C). The decrease in FRET efficiency implies
that actin-ECFP and actin-EYFP are unable to interact, thereby leading
to blockade of actin tread-milling.
3.4. Inverse invasion assay and scanning electron microscopy reveal
decrease in invasion and distortion of morphology of MDA-MB-231 cells
Actin tread-milling and actin cytoskeleton remodeling play an
essential role in invasion.We investigated the effect of HSP90 inhibition
on invasiveness of MDA-MB-231 cells by inverse invasion assay of
MDA-MB-231 cells over-expressing p-EGFP (MDA-MB-231-GFP) in
the presence or absence of 17AAG. Confocal micrographs as well as
their 3-D reconstruction show that control MDA-MB-231-GFP cells
invade thematrigel up to a height of 113 μM,whereasMDA-MB-231-
GFP cells incubated with 17AAG invade up to a height of only 16 μM
(Figs. 4A and S3) indicating decreased invasion of MDA-MB-231-GFP
cells upon HSP90 inhibition. Scanning electron microscopic investi-
gation of MDA-MB-231 cells on matrigel (about 500 μM thick)ion upon HSP90 inhibition by 17AAG. (A) Immuno-blot analysis of HSP90 immuno-
-blot analysis of αB-crystallin immuno-precipitate from total cell lysate probed by actin
P and actin-EYFP constructs. The graph represents the average FRET occurring with and
eriments. *P-value (pb0.05) is in comparison to control.
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(Fig. 4B), whereas MDA-MB-231 cells incubated with 17AAG showed
severe distortion, shrinkage and detachment from the matrigel
(Fig. 4B), thereby leading to a decrease in invasion.
Invasion of cells in the matrigel requires digestion of the matrix.
MMP2, MMP9 and MMP14 have been shown to be predominantly
involved in degradation of the matrix in tumors [32]. Extra-cellular or
surface HSP90α has been shown to be responsible for the activation of
MMP2 [24]. We observed a drastic decrease in surface HSP90α upon
HSP90 inhibition as shown by the large field (20×) confocalmicrograph
(Fig. 4C). We also observed a significant decrease in the number of the
cells expressing surface HSP90α (Fig. 4D) upon HSP90 inhibition.
3.5. Over-expression of αB-crystallin in MDA-MB-231 cells does not
abrogate the effect of HSP90 inhibition
αB-Crystallin seems to have a role in breast cancer and its over-
expression is proposed to predict poor clinical outcome in breast
cancer [33]. Since MDA-MB-231 cells express low levels of αB-
crystallin (Fig. S2), we over-expressed αB-crystallin in these cells
(CryαB-MDA-MB-231) and investigated the outcome of HSP90
inhibition. CryαB-MDA-MB-231 cells appeared to be narrower and
resembled epithelial cells more closely compared to MDA-MB-231
cells (unpublished observation). No significant change was observedFig. 4. Inhibition of HSP90 decreases invasion and surface expression of HSP90α in breast ca
treated and untreated MDA-MB-231-GFP cells. Lower panel shows the 3D reconstruction o
micrographs of control and 17AAG-treated MDA-MB-231 cells plated on matrigel. (C) Immu
Scale bar, 20 μm. (D) The graph represents the average number of cells expressing surface HS
3 independent experiments. *P-value (pb0.02) is in comparison to control.in the motility of MDA-MB-231 cells over-expressing αB-crystallin
upon HSP90 inhibition (Movies M5 and M6). Staining 17AAG-treated
CryαB-MDA-MB-231 cells for F-actin reveals decreased number of
lamellipodia and decrease in tough cortical actin bundles (Fig. 5B).
Earlier reports suggest phosphorylation-dependent (serine-59)
localization of αB-crystallin in lamellipodia in porcine lens epithelial
cells [34], and association of αB-crystallin with F-actin under stress
conditions in cardiomyocytes [35]. While αB-crystallin showed a
diffused pattern of staining in control CryαB-MDA-MB-231 cells and
in 17AAG-treated CryαB-MDA-MB-231 cells, 17AAG-treated cells
showed decreased localization of αB-crystallin at the edges of the cell
and a significant decrease in the number of lamellipodia (Fig. 5A and B).
Immuno-blot analysis revealed increase in αB-crystallin in F111 cells
and a minor increase in αB-crystallin in CryαB-MDA-MB-231 cells
accompanied by an increase in the Serine-59-phosphorylation of αB-
crystallin in F111 and CryαB-MDA-MB-231 cells upon HSP90 inhibition
(Fig. 5C). p38 MAP kinase is known to phosphorylate αB-crystallin at
Ser-59 residue [36]. Immuno-blot analysis of phospho-p38 MAP kinase
revealed no activation of p38 MAP kinase in either MDA-MB-231 or
CryαB-MDA-MB-231 cells (Fig. 5C). On the other hand, both control and
17AAG-treated F111 cells showed comparable activation of p38 MAP
kinase (Fig. 5C). In contrast to the previous report [34], we observed
decreased localization of phospho-Ser-59-αB-crystallin to the lamelli-
podia inCryαB-MDA-MB-231 cells uponHSP90 inhibition (unpublishedncer cells. (A) Upper panel shows confocal images of inverse invasion assay for 17AAG-
f the confocal images of inverse invasion assay. Scale bar, 50 μm. (B) Scanning electron
no-localization of surface HSP90α for 17AAG-treated and untreated MDA-MB-231 cells.
P90α per field from 4 different fields. Error bars indicate ±SEM of 4 different fields from
Fig. 5. Localization and expression of αB-crystallin and actin, and expression levels of heat shock proteins and pro-survival signaling molecules in CryαB-MDA-MB-231 cells upon
HSP90 inhibition. (A) Immunofluorescence images ofαB-crystallin for 17AAG-treated and untreated CryαB-MDA-MB-231 cells. Scale bar, 10 μm. (B) Rhodamine-phalloidin staining
for actin in 17AAG-treated and untreated CryαB-MDA-MB-231 cells. Scale bar, 10 μm (C) Immuno-blot analysis of αB-crystallin, p-Ser59-αB-crystallin, p-Thr180/Tyr182-P-38 MAP
kinase, P-38 MAP kinase (upper panel) and of HSP90, HSP90α, HSP90β and HSP70 (lower panel) of 17-AAG treated and untreated F111, MDA-MB-231 and CryαB-MDA-MB-231
cells. (D) Immuno-blot analysis for Akt1/2 and p-Thr308-Akt1/2 expression in 17AAG-treated and untreated F111, MDA-MB-231 and CryαB-MDA-MB-231 cells. GAPDHwas used as
a loading control.
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59-αB-crystallin (Fig. 5C).
We have investigated whether over-expression of αB-crystallin
leads to any alteration in the expression of other heat shock proteins.
Upon HSP90 inhibition, we observed a significant increase in the
levels of HSP70, HSP90 and HSP90α, but not in HSP90β in CryαB-
MDA-MB-231 cells (Fig. 5C). Further we did not observe any change in
the levels of Akt and p-Thr308-Akt in CryαB-MDA-MB-231 cells upon
HSP90 inhibition (Fig. 5D). Our data shows that CryαB-MDA-MB-231
cells show similar cell motility profile, pattern of actin distribution,
and profile of different HSPs as shown by MDA-MB-231 cells upon
HSP90 inhibition.
3.6. Expression of signaling molecules involved in cell adhesion, survival
and transwell migration assay and scanning electron microscopic study
of CryαB-MDA-MB-231 cells
Because we observed no significant change in the motility of
MDA-MB-231 cells over-expressing αB-crystallin upon HSP90 inhibi-
tion, we assessed the profile of signaling molecules involved in cell
proliferation and adhesion. No change in the levels of Rac1 and Cdc42
(Fig. S1) aswell as RhoA (Fig. 6A)was observed in CryαB-MDA-MB-231
cells upon HSP90 inhibition. In contrast MDA-MB-231 cells show a
significant decrease in the levels of RhoA, upon HSP90 inhibition, as
shown by immuno-blot and immuno-staining experiments. We
observed no change in the levels of active or inactive Akt1/2 in both
MDA-MB-231 and CryαB-MDA-MB-231 cells upon HSP90 inhibition
(Fig. 6B).In order to investigate any alteration in migration of CryαB-MDA-
MB-231 cells upon HSP90 inhibition we performed transwell
migration assay. Though the percentage of F111, MDA-MB-231 and
CyrαB-MDA-MB-231 cells which migrated to the other side of the
membrane of the transwell decreased upon HSP90 inhibition, we
observed a minor but significant increase in the migration of CryαB-
MDA-MB-231 cells compared to that of MDA-MB-231 cells (Fig. 6C).
Scanning electron micrographs of CryαB-MDA-MB-231 cells plated on
matrigel showed that the cells adhered to the matrigel with some cells
migrating inside the matrigel. 17AAG-treated CryαB-MDA-MB-231
cells showed severe distortion in the cell morphology and rupture in
the connection of CryαB-MDA-MB-231 cells with the matrigel in
addition to impairment in cell adhesion (Fig. 6B). Together, these data
suggest that over-expression of αB-crystallin in MDA-MB-231 cells
does not lead to any observable change in the property of cell migration
and invasion upon HSP90 inhibition.4. Discussion
HSP90 inhibition has been known to induce apoptosis in cancer
cells [8,9]. We did not observe apoptosis in 17AAG-treated F111 or
MDA-MB-231 cells. The reason could be the observed increase in
levels of HSP70, HSP90 and αB-crystallin, which are known to protect
cells from heat-induced apoptosis [31]. However, importantly our
study shows that 17AAG acts as an antagonist to cancer cell motility,
migration and invasion. Increase in the level of αB-crystallin but not
that of HSP25 reveals differential activation of small heat shock
Fig. 6. Expression and localization of signaling molecules, transwell migration assay and matrigel studies for CryαB-MDA-MB-231 cells. (A) 17AAG-treated and untreated CryαB-
MDA-MB-231 cells were stained for RhoA and mDia2 (upper panel). Scale bar, 10 μm. Lower panel shows the immuno-blot of RhoA for 17AAG-treated and untreated F111, MDA-
MB-231 and CryαB-MDA-MB-231 cells. (B) Scanning electron micrographs of control and 17AAG-treated CryαB-MDA-MB-231 cells plated on matrigel. (C) Transwell migration
assay for 17AAG-treated and untreated F111, MDA-MB-231 and CryαB-MDA-MB-231 cells. The graph represents the average percentage normalized with the respective controls.
Error bars indicate ±SEM of three independent experiments done in triplicate.
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clear.
Lamellipodia and filopodia are the essential locomotory and sensory
apparatus of the cell. HSP90 inhibition leads to significant reduction in
the number of filopodia and retraction of filopodial protrusions in F111
cells (Fig. 1C). Incubation of MDA-MB-231 cells with 17AAG leads to a
significant decrease in lamellipodia, tough cortical actin bundles (see
Movie M3) as well as membrane ruffles (Fig. 1D). The cellular
protrusions are predominantly composed of array of actin bundles
arranged parallely in filopodia and trajectorially in lamellipodia.
Koestler et al. [37] have shown that the curved arrangement of F-actin
bundles at the leading edges during cell migration leads to pausing and
retraction of the cell. Our analysis of the F-actin-stained cells shows
arrangement of F-actin parallel to the cell membrane of the migrating
cells indicating pause, and not retraction, in cell motility. Dynamic
equilibrium between G-actin and F-actin, predominantly at the lagging
and leading edges of themigrating cell is important for the formation of
cellular protrusions. We observed no change in the levels of total actin
but a decrease in F-actin uponHsp90 inhibition, suggesting a shift in the
equilibrium fromF- toG-actin. The level ofArp2/3 does not change upon
HSP90 inhibition, suggesting that molecules involved in actin poly-
merization are not responsible for HSP90 inhibition-mediated decrease
in F-actin.
HSP90 inhibition led to a decrease in the efficiency of FRET between
actin molecules. We hypothesize that HSP90 interacts with and
sequesters G-actin, and hence does not allow the polymerization of
G-actin monomers. In fact, co-immuno-precipitation experiments show
interaction of HSP90 with G-actin. HSP90 inhibition leads to, inter alia,
increase in the level of HSP90 which sequesters more G-actin, shifting
the polymerization–depolymerization equilibrium predominantly at
the leading edge of themigrating cells. This processmight contribute to
the observed decrease in numbers of filopodia and lamellipodia uponHSP90 inhibition (Fig. 3A and C). Interaction of HSP90 with its client
proteins is an ATP-dependent process which gets disrupted due to
HSP90 inhibition by 17AAG [3,5]. In contrast, interaction of HSP90 with
G-actin seems to beATP-independent aswe observed an increase rather
than a decrease in the interaction of HSP90 with G-actin. The increased
interaction of HSP90with G-actin can be co-relatedwith the increase in
the levels of HSP90, upon HSP90 inhibition by 17AAG, which is due to
the increase in the activity of heat shock transcription factor 1 (HSF1)
(unpublished observation). The decrease in the levels of RhoA upon
HSP90 inhibition suggests a decrease in the generation of contractile
forces necessary for cell motility.
Though HSP90-dependent phosphorylation of focal adhesion
kinase (FAK) is shown to be important in VEGFR2-mediated cell
migration [38], we did not observe change in the levels of
phosphorylated or unphosphorylated forms of FAK in MDA-MB-231
cells. We found that though the total level of paxillin, a focal adhesion-
associated adaptor protein, did not change, the level of its active form
decreased in F111 cells upon HSP90 inhibition.
Actin dynamics-mediated cellular protrusion is responsible for cell
migration and invasion of matrix, the primary step in cancer cell
metastasis. MDA-MB-231 cells underwent severe distortion of mor-
phology (Fig. 4B), had decreased lamellipodia and showed decreased
matrigel invasion upon HSP90 inhibition (Fig. 4A) establishing a
correlation between actin dynamics, formation of cellular appendages
and cell invasion in the context of HSP90 and its inhibition. Extra-
cellular HSP90 plays an important role in immune response, invasion
andmetastasis by its interaction with several extra-cellular clients such
as dengue virus receptor, ErbB2 etc [39]. Further, extra-cellular HSP90α
has an important role in the activation ofMMP2 [24], degradation of the
extra-cellularmatrix and invasion; cell-impermeant inhibitors of HSP90
such as DMAG-N-oxide inhibit HSP90α-mediated invasion of melano-
ma cells [26]. Our results suggest a decrease in the surface localization of
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of HSP90α upon HSP90 inhibition. It is possible that interaction of
17AAG with HSP90α might decrease its translocation from the
cytoplasm to the cell surface.
Moyano et al., have shown that over-expression of αB-crystallin in
transformed human mammary epithelial cells leads to increased cell
migration and luminal filling in 3D basement membrane cultures
compared to normal human mammary epithelial cells. Since we
observed a marginal increase in αB-crystallin expression upon HSP90
inhibition in F111 cells,we investigatedwhether over-expression ofαB-
crystallin could counter the effect of HSP90 inhibition in MDA-MB-231
cells. Overall, over-expression ofαB-crystallin did not significantly alter
the effect of HSP90 inhibition on MDA-MB-231 cells.
Taken together, our present findings illustrate the mechanisms
underlying inhibition of cell migration and invasion upon HSP90
inhibition through multiple pathways such as binding to G-actin and
inhibiting its polymerization, decreasingRhoA levels and decreasing the
translocation of HSP90α to the cell surface. Over-expression of αB-
crystallinwas not able to rescue theeffect ofHSP90 inhibition. Our study
is useful in understanding the functional role of HSP90 in maintaining
cellular homeostasis and as a proof of principle of the clinical usefulness
of 17AAG against cancer.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.bbamcr.2010.09.012.
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